Large Pharma Acquisition -- Alexion Buys Synageva for $8.4 Billion
May 06, 2015 at 11:19 AM EDT
Alexion's acquisition of Synageva's treatment pipeline "creates the most robust rare disease pipeline in biotech," the companies said. read more
